Wednesday, May 20th, 2020

Process developers of COVID-19 vaccines need to develop, scale up and build sustainable mass production within the fastest timelines ever in a pandemic situation, and yet must ensure the safety, purity, quality and potency of their vaccines.

We support these challenges with an integrated platform approach that achieves fast development, banking and characterization of your cell line,  rapid characterization and lot release testing of your vaccine, expedited delivery of your ready to use media and proven end-to-end single use manufacturing.

Learn More